C5's Pharmaceuticals and Biotech Conferences
Product Overview
C5 brings together eminent in-house counsel from the world's largest pharma and biotech companies and their expert advisors in an outstanding panel of speakers. C5's series of Biotech Patenting, IP, FTO and Regulatory conferences are the one place expert practitioners come to learn and discuss the most recent and vital changes facing the industry today.
- Pharma & Biotech Patent Litigation
- Biotech Patenting
- Freedom to Operate
- Obstetric Malpractice
- Pharmaceutical Patent Lifecycle Management
- EU Pharmaceutical Law & Regulation
23 Professionals recommend C5's Pharmaceuticals and Biotech Conferences
All professionals that recommend C5's Pharmaceuticals and Biotech Conferences
-
Bjørn von Ryberg, Partner at ABSALON AdvokatfirmaCopenhagen Area, Denmark
I have chaired and/or participated in several C5 conferences. It is my experience that they are the best on the market when it comes to high level presentations on intellectual property and regulatory issues.- March 15, 2012
-
Stratmann Klemens, Unternehmensinhaber - Partner at Hoffmann Eitle Patent- und RechtsanwälteMunich Area, Germany
very useful conference series with comprehensive high quality presentations, an excellent opportunity for networking, important legal update for my daily practice- March 6, 2012
-
great opportunity to meet and share experiences and views with all stakeholders relevant for pharma patent litigation including judges, litigation lawyers, originators, generics- March 2, 2012
-
Nick Bassil, Owner at Kilburn & StrodeLondon, United Kingdom
Tremendously useful conference series, with detailed legal updates and great opportunities for networking.- March 1, 2012
-
Karolyn Fletcher, Legal Director at Bristol-Myers SquibbSouthall, United Kingdom
One of the best specialised conferences for the pharma industry, with some excellent speakers (e.g. Feb 2012 - Adela Willaims, Victoria Kitcatt) who give very clear, concise and pragmatic advice, rather than purely theoretical updates. Given the quality of the delegates as well as the speakers, the networking opportunities are usually good too.- March 1, 2012
-
Catherine Longeval, Independent Law Practice ProfessionalBrussels Area, Belgium
I found the program of last year's European Pharma Regulatory Law Conference in Brussels (on Sept 22nd, 2012) very comprehensive and enjoyed meeting other industry experts on that occasion.- February 29, 2012
-
Petr Kusy, Attorney at Čermák a spol.Prague, The Capital, Czech Republic
I recommend this product
- February 29, 2012
-
Clare Dunne, Manager, Patent Focus at IMS HealthLondon, United Kingdom
Well-organized conferences with interesting talks and a good opportunity to meet experts in their fields- February 29, 2012
-
Phil Carey, Senior Associate Solicitor, Intellectual Property (Patent Litigation) at Winston & StrawnLondon, United Kingdom
I recently attended the C5 Pharma/Biotech conferences in Amsterdam (Patent Litigation) and London (EU Law and Regulation). A good variety of subject matter means an education for all attendees. Having spoken/chaired at both meetings, I can also vouch for the professional and friendly approach from the organisers at C5.- February 29, 2012
-
Julian Hitchcock, Counsel at Lawford Davies DenoonUnited Kingdom
I echo the remarks made by colleagues. A very high standard indeed; well focused and authoritative.- September 20, 2011